שאלה משלב א׳ ברפואה גרעינית · מועד 2023, שאלה 88

Correct: B — the statement that is NOT an advantage is that F-DOPA is used to select patients for targeted radionuclide therapy; it is MIBG that serves as the theranostic partner for I-131 MIBG treatment. Option A is true because DOPA has higher sensitivity and specificity; option C is true because imaging follows shortly after injection rather than at 24 hours; option D is true because the shorter half-life reduces the radiation dose.

מקור: volterrany 562-565 + 544-548